MR1: an unconventional twist in the tail by Phalora, P, Klenerman, P

Direct ex vivo evaluation of long-lived protective antiviral memory B cell responses against hepatitis B virus. by Ward, S, Phalora, P, Bradshaw, D, Leyendeckers, H, Klenerman, P

TLR signaling in human antigen-presenting cells regulates MR1-dependent activation of MAIT cells by Ussher, J, van Wilgenburg, B, Hannaway, R, Ruustal, K, Phalora, P, Kurioka, A, Hansen, T, Willberg, C, Phillips, R, Klenerman, P

Molecular analyses define Vα7.2-Jα33+ MAIT-cell depletion in HIV infection: a case-control study by Klenerman, P, Ussher, J, Phalora, P, Cormac, C, Rachel, H, A, R, Huldrych F., G, Philip, G, Rodney E., P, Christian B., W

Human MAIT cell activation in vitro by Hagel, JP, Garner, LC, Bilton, M, Mehta, H, Leng, T, Hackstein, C-P, Phalora, P, Amini, A, Akther, HD, Provine, NM, Edmans, M, Willberg, CB, Klenerman, P

The impact of immunoglobulin in acute HIV infection on the HIV reservoir: a randomized controlled trial by Tiraboschi, J, Ray, S, Patel, K, Teague, A, Pace, M, Phalora, P, Robinson, N, Hopkins, E, Meyerowitz, J, Wang, Y, Cason, J, Kaye, S, Sanderson, J, Klenerman, P, Fidler, S, Frater, J, Fox, J

The impact of immunoglobulin in acute HIV infection on the HIV reservoir: a randomized controlled trial by Tiraboschi, J, Ray, S, Patel, K, Teague, A, Pace, M, Phalora, P, Robinson, N, Hopkins, J, Meyerowitz, J, Wang, Y, Cason, J, Kaye, S, Sanderson, J, Klenerman, P, Fidler, S, Frater, A, Fox, J

Lack of effect of Maraviroc intensification on blood and gut reservoir. by Tiraboschi, J, Ray, S, Patel, K, Pace, M, Phalora, P, Robinson, N, Hopkins, E, Meyerowitz, J, Wang, Y, Davies, O, Mant, C, Cason, J, Kaye, S, Sanderson, J, Fidler, S, Klenerman, P, Frater, J, Fox, J

Human MAIT cells respond to and suppress HIV-1 by Phetsouphanh, C, Phalora, P, Hackstein, C-P, Thornhill, J, Munier, CML, Meyerowitz, J, Murray, L, VanVuuren, C, Goedhals, D, Drexhage, L, Moore, R, Sattentau, QJ, Mak, JY, Fairlie, DP, Fidler, S, Kelleher, AD, Frater, J, Klenerman, P

Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses by McNaughton, AL, Paton, RS, Edmans, M, Youngs, J, Wellens, J, Phalora, P, Fyfe, A, Belij-Rammerstorfer, S, Bolton, JS, Ball, J, Carnell, GW, Dejnirattisai, W, Dold, C, Eyre, DW, Hopkins, P, Howarth, A, Kooblall, K, Klim, H, Leaver, S, Lee, LN, López-Camacho, C, Lumley, SF, Macallan, DC, Mentzer, AJ, Provine, NM, Ratcliff, J, Slon-Compos, J, Skelly, D, Stolle, L, Supasa, P, Temperton, N, Walker, C, Wang, B, Wyncoll, D, Simmonds, P, Lambe, T, Baillie, JK, Semple, MG, Openshaw, PJM, Obolski, U, Turner, M, Carroll, M, Mongkolsapaya, J, Screaton, G, Kennedy, SH, Jarvis, L, Barnes, E, Dunachie, S, Lourenço, J, Matthews, PC, Bicanic, T, Klenerman, P, Gupta, S, Thompson, CP